Support from the Spanish Nanoscience Action NAN200409270C3-1/2, Ciber CB06/01/0026 and from the Consolider program, CSD2006-00012 is gratefully acknowledged. We thank Ms. Ana Pérez for her valuable help with the FTIR measurements. One of the authors, M.A., acknowledges support of a contract from the “Juan de la Cierva” program (project PPQ2003-04986). S.I. acknowledges the support of the “Ramón y Cajal” program.
Full Paper
Antibody-Functionalized Hybrid Superparamagnetic Nanoparticles†
Article first published online: 30 APR 2007
DOI: 10.1002/adfm.200600560
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Arruebo, M., Fernández-Pacheco, R., Velasco, B., Marquina, C., Arbiol, J., Irusta, S., Ibarra, M. R. and Santamaría, J. (2007), Antibody-Functionalized Hybrid Superparamagnetic Nanoparticles. Advanced Functional Materials, 17: 1473–1479. doi: 10.1002/adfm.200600560
- †
Publication History
- Issue published online: 1 JUN 2007
- Article first published online: 30 APR 2007
- Manuscript Revised: 4 NOV 2006
- Manuscript Received: 26 JUN 2006
Funded by
- Spanish Nanoscience Action. Grant Number: NAN200409270C3-1/2
- Consolider program. Grant Number: CSD2006-00012
- “Juan de la Cierva” program. Grant Number: PPQ2003-04986
- “Ramón y Cajal” program
- Abstract
- References
- Cited By
Keywords:
- Biocompatible materials;
- Core/shell nanoparticles;
- Iron oxides;
- Silicon;
- Superparamagnetism
Graphical Abstract

Superparamagnetic hybrid nanoparticles are obtained; they consist of an inner iron oxide core coated by a silica shell (see figure) and are covalently coupled to a monoclonal antibody (anti-hCG). This has been verified by an immunochromatographic assay. These results point to the potential of the hybrid nanoparticles prepared for use as enhanced contrast agents in magnetic resonance imaging applications.
Abstract
Superparamagnetic hybrid nanoparticles (ca. 80 nm) are obtained. They consist of an inner iron oxide core coated by a silica shell, which is in turn functionalized with amine or carboxyl groups and covalently coupled to a monoclonal antibody (anti-hCG; hCG = human chorionic gonadotropin). The prepared nanoparticles show a specific magnetic moment (per gram of iron) that is comparable to that measured for commercial superparamagnetic iron oxide preparations. The bioactivity of the antibody-conjugated magnetic nanoparticles is verified by a standard bioassay. These results indicate the potential of the hybrid nanoparticles prepared for use as enhanced contrast agents in magnetic resonance imaging applications.

1616-3028/asset/2126_centre.gif?v=1&s=c88ccad5117044f38366989c886e57ea3f100c56)
